Item Type | Name |
Concept
|
Drug Resistance
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Drug Resistance, Multiple
|
Academic Article
|
Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents.
|
Academic Article
|
Silence is golden: gene hypermethylation and survival in large-cell lymphoma.
|
Academic Article
|
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
|
Academic Article
|
Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
|
Academic Article
|
Temozolomide: realizing the promise and potential.
|
Academic Article
|
Molecular mechanisms of resistance and toxicity associated with platinating agents.
|
Academic Article
|
Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.
|
Academic Article
|
Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.
|
Academic Article
|
Genetic variants contributing to daunorubicin-induced cytotoxicity.
|
Academic Article
|
Role of copper transporters in resistance to platinating agents.
|
Academic Article
|
Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.
|
Academic Article
|
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
|
Academic Article
|
Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.
|
Academic Article
|
PACdb: a database for cell-based pharmacogenomics.
|
Academic Article
|
Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity.
|
Academic Article
|
Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
|
Academic Article
|
Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer.
|
Academic Article
|
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.
|
Academic Article
|
Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.
|
Academic Article
|
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
|
Academic Article
|
Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidine.
|
Academic Article
|
Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
|
Academic Article
|
The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells.
|
Academic Article
|
Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
|
Academic Article
|
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
|
Academic Article
|
Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
|
Academic Article
|
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
|
Academic Article
|
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations.
|
Academic Article
|
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.
|
Academic Article
|
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
|
Academic Article
|
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.
|
Academic Article
|
Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
|
Academic Article
|
Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.
|
Academic Article
|
Mechanisms of resistance to the toxicity of cyclophosphamide.
|
Academic Article
|
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
|
Academic Article
|
The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.
|
Academic Article
|
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
|
Academic Article
|
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.
|
Academic Article
|
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.
|
Academic Article
|
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine.
|